In the phase 3 clinical trial by John Yaxley and colleagues,1 the only significant differences between radical retropubic prostatectomy and robot-assisted prostatectomy were observed in hospital stay, blood loss, duration of surgery (minutes), time in operating room (minutes), and stress levels, which were all lower in the robot-assisted surgery group. However, the authors did not perform a cost-benefit and cost-effectiveness study, which could be very interesting because there are no significant differences in oncological or functional outcomes.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lwIaqy
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: 18 April 2017 Source: Cell Reports, Volume 19, Issue 3 Author(s): David Estoppey, Chia Min Lee, Marco Janoschke, Boon He...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oLOayI via IFTTT
-
Abstract Functionalised electrospun polyamide-6 (PA-6) nanofibres incorporating gadolinium oxide nanoparticles conjugated to zinc tetracar...
-
Cytokine-dependent renewal of stem cells is a fundamental requisite for tissue homeostasis and regeneration. Spermatogonial progenitor cells...
-
Yahoo Health Ken Brookes Lost 102 Pounds: 'I Never Want to Go Back to Being Unhealthy' Yahoo Health My wife died of ovarian ...
-
Abstract It has been documented that the purification of inclusion bodies from Escherichia coli by size exclusion chromatography (SEC) ma...
-
Abstract This paper addresses the hybrid consensus-based formation keeping problem for nonholonomic mobile robots in the presence of a nov...
-
Abstract Background Cells in the intervertebral disc have unique phenotypes and marker genes that separate the nucleus pulposus (NP), an...
-
History Day has been the vehicle that creates an understanding and appreciation of history while developing the necessary 21st-century tools...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου